Chickens may fight Cancer

July 19, 2012

(This article was first published at via JPost) The common barnyard chicken could provide some very un-common clues for fighting off diseases and might even offer new ways to attack cancer, according to a team of international researchers that includes a Texas A&M University professor.

James Womack, Distinguished Professor of Veterinary Pathobiology in the College of Veterinary Medicine & Biomedical Sciences, is co-author of a paper detailing the team’s work that appears in the current issue of PNAS (Proceedings of the National Academy of Scientists). Womack was a leader in the international effort to sequence the cattle genome in 2004.
Womack and the team, comprised mostly of scientists from the Seoul National University in Korea, examined 62 White Leghorn and 53 Cornish chickens for diversity in NK-lysin, an antibacterial substance that occurs naturally in animals and is used as a method of fighting off diseases.
They were able to obtain two genetic variations of NK-lysin and the results offered two unexpected shockers: both showed abilities to fight off bacterial infections and other diseases, while one showed it could successfully fight cancer cells as well.
“It took all of us by surprise,” Womack says of the findings.
“One of the genetic variations shows it has the ability to fight against cancer cells much more aggressively than the other variation. We certainly were not looking at the cancer side of this, but there it was.”
Womack says the team selected the two breeds because Cornish and White Leghorn chickens, found throughout most of the world, have relatively diverse genetic origins.
After conducting a DNA sequence of the chickens, the team found two variations of the genes that offered clues as to their protective ability to ward off infections.
“One form appears to be more potent in killing off cancer cells than the other, and that’s the one that naturally caught our eye,” Womack adds.
“This could lead to other steps to fight cancer or in developing ways to prevent certain infections or even diseases. It’s another door that has been opened up. We are looking at similar studies right now to see if this is possible with cattle.
“The next step is to work with other animals and see if similar variants exist. We need to look for any genetic similarities to the chicken variants and then determine if these variants affect the health of the animal, but this is an exciting first step in this direction.”

bok bok bok bok bok bok bok bok

Israeli researchers develop cancer vaccine, world yawns

April 11, 2012

Notice even the London Telegraph does not mention the word Israel. Does the UK want to die of cancer before they ask for the help of Israeli science? That can be arranged.

(Carl) Here’s hoping that the BDS’ers will at least have the intellectual honesty to boycott this one too. Israeli researchers have come up with a vaccine – it’s still being tested – that fights off certain common kinds of cancers (Hat Tip: Tundra Tabloids).

Scientists have, however, found that a molecule called MUC1, which is found in high amounts on the surface of cancer cells, can be used to help the immune system detect tumours.
The new vaccine, developed by drug company Vaxil Biotheraputics along with researchers at Tel Aviv University, uses a small section of the molecule to prime the immune system so that it can identify and destroy cancer cells.
A statement from Vaxil Biotheraputics said: “ImMucin generated a robust and specific immune response in all patients which was observed after only 2-4 doses of the vaccine out of a maximum of 12 doses.
“In some of the patients, preliminary signs of clinical efficacy were observed.”
The results are still to be formally published but if further trials prove to be successful the vaccine could be available within six years.
As a therapeutic vaccine it is designed to be given to patients who are already suffering from cancer to help their bodies fight off the disease rather than to prevent disease in the first place.
Cancer cells contain high levels of MUC1 as it is thought to be involved helping tumours grow. Healthy human cells also contain MUC1, but have levels that are too low to trigger the immune system after vaccination.
When a vaccinated patient’s immune system encounters cancer cells, however, the far larger concentration of MUC1 causes it to attack and kill the tumour.
As MUC1 is found in 90 per cent of all cancers, the researchers believe it could be used to combat the growth and spread of a wide range of cancers.
In a safety trial at the Hadassah Medical Centre in Jerusalem, ten patients suffering from multiple myeloma, a form of blood cancer, have now received the vaccine.
Seven of the patients have now finished the treatment and Vaxil reported that all of them had greater immunity against cancer cells compared to before they were given the vaccine.
Vaxil added that three patients are now free of detectable cancer following the treatment.

Oh – and lest you think that Vaxil Biotheraputics doesn’t come from Israel….

Vaxil was founded in late 2006 by an experienced management team supported by leading scientists and clinicians. It is headquartered at the Weizmann Science Park, Nes –Ziona, Israel.

So why isn’t this getting more publicity? Hmmm.
I hope the BDS’ers will boycott it. Darwin would call that selection.

Get Up, Stand Up: New Study Links Prolonged Sitting With Cancer

November 4, 2011
yeshiva(’t just sit there. Get up and do something! Canadian researchers say that prolonged sitting may be responsible for a 173,000 cases of cancer in the United States each year, including breast, colon, lung, prostate and ovarian cancers.1010 WINS’ Medical Corespondent Dr. Brian McDonough said more people need to be cutting calories and keep the blood flowing.

No Brainer!

The Jews are telling you something you probably didn’t want to know….

October 28, 2010

Life is divided into the horrible and the miserable. The horrible are the cancer patients and the terminal cases… the miserable is everyone else. So, be thankful that you’re miserable. -Woody Allen 

Now the miserable will know why they are miserable. Israeli Tech will tell them if they have cancer or not… which I’m not sure the world will appreciate.

Researchers at the Technion in Haifa have developed a simple blood test that screens for cancer.

An innovative, simple blood test that can diagnose a variety of diseases, including cancer, has been developed by researchers at the Technion-Israel Institute of Technology and was just reported in a central article in the Proceedings of the [US] National Academy of Sciences.

The Technion has registered a patent on the development.
Prof. Aryeh Admon of the biology faculty claims that the test will provide doctors with a rich variety of information that until now has not been available and is suited to the trend of “personalized medicine,” in which treatment is suited to the genetic and other characteristics of the patient. The development was part of the doctoral work of Dr. Miochal Bassani- Sternberg and will help suit medication to the patient.
As opposed to current blood tests for cancer which merely note whether cancerous cells are still in the blood stream, the new test will be able to differentiate between different kinds of cancers and tumors as well as other dise

oy… saving the world with the nerd stuff.